Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 179 (5) , 367-371
- https://doi.org/10.1016/s0002-9610(00)00369-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Adjuvant therapy of resected adenocarcinoma of the pancreasInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lungInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancerCancer, 1987
- Periampullary tumors: Which ones should be resected?The American Journal of Surgery, 1985
- Current trends in the diagnosis and treatment of carcinoma of the pancreasThe American Journal of Surgery, 1983
- Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo clinic experienceThe American Journal of Surgery, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958